Article information
Full text is only aviable in PDF
References
[1.]
R. Willemze, E.S. Jaffe, G. Burg, L. Cerroni, E. Berti, S.H. Swerdlow, et al.
WHO-EORTC classification for cutaneous lymphomas.
Blood, 105 (2005), pp. 3768-3785
[2.]
F. Gallardo, R.M. Pujol.
Diagnóstico y tratamiento de los linfomas cutáneos primarios de células B.
Actas Dermosifiliogr, 95 (2004), pp. 537-547
[3.]
M.H. Vermeer, F.A. Geelen, C.W. van Haselen, P.C. van Voorst Vader, M.L. Geerts, W.A. van Vloten, et al.
Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
Arch Dermatol, 132 (1996), pp. 1304-1308
[4.]
J. Pedraz, Y. Delgado, M. Ballestero, J. Fraga, A. García-Díez, J. Fernández-Herrera.
Linfoma cutáneo de células grandes B de las piernas.
Actas Dermosifiliogr, 96 (2005), pp. 237-240
[5.]
F. Child, R. Russell-Jones, A. Wollford, E. Calonge.
Absence of t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
Br J Dermatol, 144 (2001), pp. 735-744
[6.]
F. Grange, T. Petrella, M. Beylot-Barry, P. Joly, M. D’Incan, M. Delaunay, et al.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
Blood, 103 (2004), pp. 3662-3668
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
